Advancing Pharmaceutical-Grade Ibogaine
Pharmogaine was created to support the transition of ibogaine from an inconsistent gray-market environment toward verifiable, tested, standardized and regulated pharmaceutical production.
From Gray Market to Pharmaceutical Standards
Access to a substance is not the same as access to a consistently produced pharmaceutical product. Pharmogaine advocates for the systems needed to make identity, quality and production more transparent and accountable.
Verified Identity
Clear analytical confirmation of what a pharmaceutical product contains.
Consistent Production
Defined manufacturing specifications designed to improve consistency between batches.
Analytical Testing
Testing frameworks for identity, purity, composition and relevant contaminants.
Traceability
Documented systems that support accountability throughout production and distribution.
Building the Conditions for Responsible Medical Development
Pharmaceutical development requires more than availability. It depends on defined manufacturing standards, reproducible products, clinical evidence, safety monitoring and regulatory oversight.
Learn Why Pharmaceuticalization Matters →Quality
Defined identity, purity and manufacturing controls.
Evidence
Research built around characterized and consistently produced material.
Oversight
Development within appropriate medical and regulatory frameworks.
Different Markets. Different Pathways.
The regulatory status and medical development of ibogaine varies by jurisdiction. Moving toward pharmaceutical use requires careful attention to the requirements of each market, including manufacturing, clinical evaluation, safety and regulatory review.
Explore the Regulatory Landscape →Toward a Verifiable and Regulated Future
Pharmogaine exists to make the case for moving ibogaine toward the quality, evidence and oversight expected of a modern pharmaceutical medicine.
About Pharmogaine